Current status of pediatric cancer treatment during the COVID-19 pandemic

—A questionnaire survey of childhood cancer cooperation in hospitals in Kyushu-Okinawa Area—

Abstract

Background: The COVID-19 pandemic, which began in 2020, has dragged on and changed people’s lifestyles. Pediatric cancer patients are receiving chemotherapy while taking adequate measures against COVID-19 infection.

Methods: At Kyushu-Okinawa area pediatric cancer hospitals, in June 2020 (after the first wave of COVID-19 infections in Japan) and September 2020 (after the second wave), we investigated the (1) experience with COVID-19, (2) its impact on medical care, and (3) its social and mental impact on patients and healthcare professionals. We discussed these issues at the monthly WEB conference.

Results: There were no cases of COVID-19 infection among pediatric cancer patients. The present situation had no effects on the outcomes of patients who were forced to change treatment for their underlying diseases. Visits and overnight stays of family caregivers, parent meetings, volunteer activities, nursery teachers/child life specialists, and playroom/in-hospital school management were restricted at all hospitals. Many patients and families suffered mental stress. The number of outpatients decreased. Telemedicine was provided at six facilities. Some restrictions were relaxed between the first and second waves, and the number of outpatients is now returning to normal.

Conclusion: COVID-19 rarely becomes severe in children. However, there are concerns about the effects of treatment changes and interruptions in care for hematological malignancies. These patients need not only adequate infection control but also mental care.